$EVH
Evolent Health, Inc. Stock $evh

$evh Overview Financials Valuation SEC Filings Company Website

2016 Q2 Form 10-Q Financial Statement

#000162890816000060 Filed on August 09, 2016

Income Statement

Concept	2016 Q2	2015 Q2
Revenue	$56.52M	$10.41M
YoY Change	442.71%
Cost Of Revenue	$32.80M	$7.900M
YoY Change	315.19%
Gross Profit	$23.70M	$2.500M
YoY Change	848.0%
Gross Profit Margin	41.93%	24.01%
Selling, General & Admin	$32.76M	$13.08M
YoY Change	150.39%
% of Gross Profit	138.21%	523.28%
Research & Development		$800.0K
YoY Change
% of Gross Profit		32.0%
Depreciation & Amortization	$800.0K	$200.0K
YoY Change	300.0%	-130.3%
% of Gross Profit	3.38%	8.0%
Operating Expenses	$69.15M	$21.95M
YoY Change	214.98%
Operating Profit	-$12.63M	-$11.54M
YoY Change	9.45%
Interest Expense	$0.00	-$16.80M
YoY Change	-100.0%	184.75%
% of Operating Profit
Other Income/Expense, Net	$1.000K	$0.00
YoY Change
Pretax Income	-$12.37M	$385.8M
YoY Change	-103.21%	-6595.39%
Income Tax	-$400.0K	$29.27M
% Of Pretax Income		7.59%
Net Earnings	-$8.387M	$359.9M
YoY Change	-102.33%	-6160.14%
Net Earnings / Revenue	-14.84%	3456.04%
Basic Earnings Per Share	-$0.20	$25.69
Diluted Earnings Per Share	-$0.20	$9.73
COMMON SHARES
Basic Shares Outstanding	42.59M shares	13.98M shares
Diluted Shares Outstanding	42.59M shares	36.64M shares

Balance Sheet

Concept	2016 Q2	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$132.7M	$219.4M
YoY Change	-39.52%
Cash & Equivalents	$105.1M	$219.4M
Short-Term Investments	$27.60M
Other Short-Term Assets	$7.500M	$8.300M
YoY Change	-9.64%
Inventory
Prepaid Expenses
Receivables	$30.34M	$24.04M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$170.6M	$251.6M
YoY Change	-32.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$18.47M	$0.00
YoY Change
Goodwill	$459.7M	$608.9M
YoY Change	-24.5%
Intangibles	$165.4M	$169.0M
YoY Change	-2.11%
Long-Term Investments	$27.20M
YoY Change
Other Assets	$9.859M	$151.0K
YoY Change	6429.14%
Total Long-Term Assets	$682.2M	$788.2M
YoY Change	-13.44%
TOTAL ASSETS
Total Short-Term Assets	$170.6M	$251.6M
Total Long-Term Assets	$682.2M	$788.2M
Total Assets	$852.8M	$1.040B
YoY Change	-17.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.38M	$13.53M
YoY Change	-8.54%
Accrued Expenses	$8.513M	$20.09M
YoY Change	-57.63%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$56.73M	$60.81M
YoY Change	-6.71%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$7.972M
YoY Change
Total Long-Term Liabilities	$7.972M	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$56.73M	$60.81M
Total Long-Term Liabilities	$7.972M	$0.00
Total Liabilities	$84.66M	$91.13M
YoY Change	-7.11%
SHAREHOLDERS EQUITY
Retained Earnings	$175.2M	$322.8M
YoY Change	-45.71%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$537.7M	$654.2M
YoY Change
Total Liabilities & Shareholders Equity	$852.8M	$1.040B
YoY Change	-17.99%

Cashflow Statement

Concept	2016 Q2	2015 Q2
OPERATING ACTIVITIES
Net Income	-$8.387M	$359.9M
YoY Change	-102.33%	-6160.14%
Depreciation, Depletion And Amortization	$800.0K	$200.0K
YoY Change	300.0%	-130.3%
Cash From Operating Activities	-$1.120M	-$5.810M
YoY Change	-80.72%	-253.7%
INVESTING ACTIVITIES
Capital Expenditures	-$3.910M	-$1.020M
YoY Change	283.33%	-180.95%
Acquisitions
YoY Change
Other Investing Activities	-$910.0K	$17.07M
YoY Change	-105.33%	-55.56%
Cash From Investing Activities	-$4.810M	$16.05M
YoY Change	-129.97%	-59.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-230.0K	209.1M
YoY Change	-100.11%	-21884.38%
NET CHANGE
Cash From Operating Activities	-1.120M	-5.810M
Cash From Investing Activities	-4.810M	16.05M
Cash From Financing Activities	-230.0K	209.1M
Net Change In Cash	-6.160M	219.4M
YoY Change	-102.81%	416.16%
FREE CASH FLOW
Cash From Operating Activities	-$1.120M	-$5.810M
Capital Expenditures	-$3.910M	-$1.020M
Free Cash Flow	$2.790M	-$4.790M
YoY Change	-158.25%	-290.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	evh	Net Income Loss Attributableto Noncontrolling Interest Includedin Computationof Diluted Earnings Per Share When Net Income Exists During Period NetIncomeLossAttributabletoNoncontrollingInterestIncludedinComputationofDilutedEarningsPerShareWhenNetIncomeExistsDuringPeriod	3424000	USD
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.94
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-3.06
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.94
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001628908
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Evolent Health, Inc.
	evh	Adjustmentsto Additional Paidin Capital Adjustmentfrom Adoptionof New Accounting Principle AdjustmentstoAdditionalPaidinCapitalAdjustmentfromAdoptionofNewAccountingPrinciple	468000	USD
CY2015	evh	Adjustmentsto Additional Paidin Capital Income Tax Benefitfrom Offering Reorganization AdjustmentstoAdditionalPaidinCapitalIncomeTaxBenefitfromOfferingReorganization	2144000	USD
	evh	Adjustmentsto Additional Paidin Capital Noncash Issuanceof Common Stock AdjustmentstoAdditionalPaidinCapitalNoncashIssuanceofCommonStock	21810000	USD
CY2015	evh	Adjustmentsto Additional Paidin Capital Noncash Issuanceof Common Stock AdjustmentstoAdditionalPaidinCapitalNoncashIssuanceofCommonStock	21810000	USD
	evh	Adjustmentsto Additional Paidin Capital Noncash Issuanceof Common Stock AdjustmentstoAdditionalPaidinCapitalNoncashIssuanceofCommonStock	0	USD
	evh	Adjustmentto Additional Paidin Capital Effectsof Merger AdjustmenttoAdditionalPaidinCapitalEffectsofMerger	34875000	USD
	evh	Adjustmentto Additional Paidin Capital Effectsof Merger AdjustmenttoAdditionalPaidinCapitalEffectsofMerger	0	USD
	evh	Adjustmentto Additional Paidin Capital Reclassificationof Deferred Offering Costs Acquired AdjustmenttoAdditionalPaidinCapitalReclassificationofDeferredOfferingCostsAcquired	3154000	USD
	evh	Adjustmentto Additional Paidin Capital Reclassificationof Deferred Offering Costs Acquired AdjustmenttoAdditionalPaidinCapitalReclassificationofDeferredOfferingCostsAcquired	0	USD
CY2014	evh	Business Acquisition Pro Forma Adjustments Removalof Transaction Costs BusinessAcquisitionProFormaAdjustmentsRemovalofTransactionCosts	1200000	USD
CY2015	evh	Business Acquisition Pro Forma Adjustments Removalof Transaction Costs BusinessAcquisitionProFormaAdjustmentsRemovalofTransactionCosts	-1200000	USD
CY2015Q2	evh	Business Acquisition Pro Forma Net Income Loss Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossAttributabletoNoncontrollingInterest	-11828000	USD
	evh	Business Acquisition Pro Forma Net Income Loss Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossAttributabletoNoncontrollingInterest	-17930000	USD
CY2016Q2	evh	Business Acquisition Pro Forma Net Income Loss Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossAttributabletoNoncontrollingInterest	-3612000	USD
	evh	Business Acquisition Pro Forma Net Income Loss Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossAttributabletoNoncontrollingInterest	-53845000	USD
CY2015Q2	evh	Business Acquisition Pro Forma Net Income Loss Including Portion Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossIncludingPortionAttributabletoNoncontrollingInterest	-30886000	USD
	evh	Business Acquisition Pro Forma Net Income Loss Including Portion Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossIncludingPortionAttributabletoNoncontrollingInterest	-45481000	USD
CY2016Q2	evh	Business Acquisition Pro Forma Net Income Loss Including Portion Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossIncludingPortionAttributabletoNoncontrollingInterest	-11999000	USD
	evh	Business Acquisition Pro Forma Net Income Loss Including Portion Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossIncludingPortionAttributabletoNoncontrollingInterest	-184031000	USD
CY2015Q2	evh	Common Stock Numberof Classes CommonStockNumberofClasses	2	class
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-276000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	9513000	USD
	us-gaap	Depreciation Depreciation	1500000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	984000	USD
CY2015Q2	evh	Costof Goodsand Services Sold Excluding Depreciationand Amortization CostofGoodsandServicesSoldExcludingDepreciationandAmortization	7887000	USD
	evh	Costof Goodsand Services Sold Excluding Depreciationand Amortization CostofGoodsandServicesSoldExcludingDepreciationandAmortization	7887000	USD
CY2016Q2	evh	Costof Goodsand Services Sold Excluding Depreciationand Amortization CostofGoodsandServicesSoldExcludingDepreciationandAmortization	32779000	USD
	evh	Costof Goodsand Services Sold Excluding Depreciationand Amortization CostofGoodsandServicesSoldExcludingDepreciationandAmortization	61445000	USD
CY2016Q2	evh	Income Lossfrom Equity Method Investments Services Agreement IncomeLossfromEquityMethodInvestmentsServicesAgreement	100000	USD
	evh	Income Lossfrom Equity Method Investments Services Agreement IncomeLossfromEquityMethodInvestmentsServicesAgreement	100000	USD
CY2015Q4	evh	Income Tax Expense Benefit Continuing Operations Adjustmentof Deferred Tax Asset Liability Expectedto Reverse Outsideof Carryforward Period IncomeTaxExpenseBenefitContinuingOperationsAdjustmentofDeferredTaxAssetLiabilityExpectedtoReverseOutsideofCarryforwardPeriod	6200000	USD
CY2015Q2	evh	Incremental Common Shares Attributableto Dilutive Effectof Conversionof Common Stock IncrementalCommonSharesAttributabletoDilutiveEffectofConversionofCommonStock	5007000	shares
	evh	Incremental Common Shares Attributableto Dilutive Effectof Conversionof Common Stock IncrementalCommonSharesAttributabletoDilutiveEffectofConversionofCommonStock	2517000	shares
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	318000	USD
CY2016Q2	evh	Incremental Common Shares Attributableto Dilutive Effectof Conversionof Common Stock IncrementalCommonSharesAttributabletoDilutiveEffectofConversionofCommonStock	0	shares
	evh	Incremental Common Shares Attributableto Dilutive Effectof Conversionof Common Stock IncrementalCommonSharesAttributabletoDilutiveEffectofConversionofCommonStock	0	shares
CY2016Q2	evh	Incremental Common Shares Attributableto Dilutive Effectof Conversionof Convertible Preferred Stock IncrementalCommonSharesAttributabletoDilutiveEffectofConversionofConvertiblePreferredStock	0	shares
	evh	Incremental Common Shares Attributableto Dilutive Effectof Conversionof Convertible Preferred Stock IncrementalCommonSharesAttributabletoDilutiveEffectofConversionofConvertiblePreferredStock	0	shares
CY2015Q2	evh	Net Income Loss Attributableto Noncontrolling Interest Includedin Computationof Diluted Earnings Per Share When Net Income Exists During Period NetIncomeLossAttributabletoNoncontrollingInterestIncludedinComputationofDilutedEarningsPerShareWhenNetIncomeExistsDuringPeriod	3424000	USD
CY2015Q2	evh	Incremental Common Shares Attributableto Dilutive Effectof Conversionof Convertible Preferred Stock IncrementalCommonSharesAttributabletoDilutiveEffectofConversionofConvertiblePreferredStock	15806000	shares
	evh	Incremental Common Shares Attributableto Dilutive Effectof Conversionof Convertible Preferred Stock IncrementalCommonSharesAttributabletoDilutiveEffectofConversionofConvertiblePreferredStock	18949000	shares
CY2016Q2	evh	Net Income Loss Attributableto Noncontrolling Interest Includedin Computationof Diluted Earnings Per Share When Net Income Exists During Period NetIncomeLossAttributabletoNoncontrollingInterestIncludedinComputationofDilutedEarningsPerShareWhenNetIncomeExistsDuringPeriod	0	USD
	evh	Net Income Loss Attributableto Noncontrolling Interest Includedin Computationof Diluted Earnings Per Share When Net Income Exists During Period NetIncomeLossAttributabletoNoncontrollingInterestIncludedinComputationofDilutedEarningsPerShareWhenNetIncomeExistsDuringPeriod	0	USD
CY2015	evh	Net Income Portion Attributableto Parent Priorto Reorganization NetIncomePortionAttributabletoParentPriortoReorganization	-28165000	USD
CY2015	evh	Net Income Portion Attributableto Parent Subsequentto Reorganization NetIncomePortionAttributabletoParentSubsequenttoReorganization	347979000	USD
	evh	Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issued Value NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedValue	0	USD
	evh	Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issued Value NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedValue	10534000	USD
CY2016Q2	evh	Numberof Partners Holding Equity Interest NumberofPartnersHoldingEquityInterest	1	partner
CY2015Q4	evh	Prepaid Expenseand Other Assets Current Related Parties PrepaidExpenseandOtherAssetsCurrentRelatedParties	1220000	USD
CY2016Q2	evh	Prepaid Expenseand Other Assets Current Related Parties PrepaidExpenseandOtherAssetsCurrentRelatedParties	1125000	USD
CY2016Q2	evh	Tax Receivables Agreement Percentof Tax Savingstobe Paid TaxReceivablesAgreementPercentofTaxSavingstobePaid	0.85
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	16699000	USD
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	12375000	USD
CY2015Q4	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	13311000	USD
CY2016Q2	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	11689000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	20381000	USD
CY2016Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	30337000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6047000	USD
CY2016Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8513000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1233000	USD
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2723000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	342063000	USD
CY2016Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	361895000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14730000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9045000	USD
CY2015Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6154000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6154000	USD
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4709000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9513000	USD
CY2015Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	800000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	800000	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2600000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5200000	USD
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19036000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18514000	shares
CY2015Q4	us-gaap	Assets Assets	1015514000	USD
CY2016Q2	us-gaap	Assets Assets	852801000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	184463000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	170557000	USD
CY2015Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.61
CY2016Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.20
CY2015Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.61
CY2016Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.20
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-3.06
CY2015Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-19058000	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-27551000	USD
CY2016Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-8387000	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-130186000	USD
CY2015Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	44676000	USD
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	89826000	USD
CY2016Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	56518000	USD
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	109160000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	98000	USD
CY2015Q2	us-gaap	Capitalized Computer Software Amortization CapitalizedComputerSoftwareAmortization	100000	USD
	us-gaap	Capitalized Computer Software Amortization CapitalizedComputerSoftwareAmortization	100000	USD
CY2016Q2	us-gaap	Capitalized Computer Software Amortization CapitalizedComputerSoftwareAmortization	300000	USD
	us-gaap	Capitalized Computer Software Amortization CapitalizedComputerSoftwareAmortization	500000	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	13065000	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	219367000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	145726000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	105138000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	219367000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-40588000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	39014000	USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2015Q2	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	894000	USD
	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	2184000	USD
CY2016Q2	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	0	USD
	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	0	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-400000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	29273000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1360000	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	14835000	USD
CY2016Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	18848000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	21318000	USD
CY2016Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	19958000	USD
CY2015Q2	us-gaap	Depreciation Depreciation	200000	USD
	us-gaap	Depreciation Depreciation	200000	USD
CY2016Q2	us-gaap	Depreciation Depreciation	800000	USD
CY2015Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	984000	USD
CY2016Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3612000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6983000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	984000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6983000	USD
CY2015Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	10185000	USD
CY2016Q2	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	10717000	USD
CY2015Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	828000	USD
CY2016Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1131000	USD
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	25.69
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	40.69
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.10
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.73
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	10.96
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.10
CY2015Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.076
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.078
CY2016Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.030
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.007
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	21925000	USD
CY2016Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	16991000	USD
CY2015Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	100000	USD
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	100000	USD
CY2016Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	7766000	USD
CY2015Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
CY2016Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7766000	USD
CY2016Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7766000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5848000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11058000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	169000000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	176500000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	163152000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	165442000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	0	USD
CY2015Q2	us-gaap	Gain Loss On Sale Of Previously Unissued Stock By Subsidiary Or Equity Investee Nonoperating Income GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome	414133000	USD
	us-gaap	Gain Loss On Sale Of Previously Unissued Stock By Subsidiary Or Equity Investee Nonoperating Income GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome	414133000	USD
CY2016Q2	us-gaap	Gain Loss On Sale Of Previously Unissued Stock By Subsidiary Or Equity Investee Nonoperating Income GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome	0	USD
	us-gaap	Gain Loss On Sale Of Previously Unissued Stock By Subsidiary Or Equity Investee Nonoperating Income GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome	0	USD
CY2015Q4	us-gaap	Goodwill Goodwill	608903000	USD
CY2016Q2	us-gaap	Goodwill Goodwill	459703000	USD
CY2015Q2	us-gaap	Goodwill Goodwill	608900000	USD
CY2015Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2016Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	160600000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	160600000	USD
CY2015Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	49900000	USD
CY2016Q2	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	8800000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	385761000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	374442000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12370000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-187637000	USD
CY2015Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-16846000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-28165000	USD
CY2016Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-14000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-14000	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29273000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29273000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29300000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-371000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-400000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1400000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1359000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1113000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2975000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-10165000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9956000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	949000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2524000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-7809000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	4013000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-2629000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-4934000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	91000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1007000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	429000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-1194000	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	163152000	USD
CY2016Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	165442000	USD
CY2015Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	13000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	13000	USD
CY2016Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	272000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	551000	USD
CY2015Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2016Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	2986000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	80935000	USD
CY2016Q2	us-gaap	Liabilities Liabilities	84657000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1015514000	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	852801000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	59506000	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	56727000	USD
CY2015Q2	us-gaap	License And Services Revenue LicenseAndServicesRevenue	7711000	USD
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	7711000	USD
CY2016Q2	us-gaap	License And Services Revenue LicenseAndServicesRevenue	46130000	USD
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	87465000	USD
CY2015Q4	us-gaap	Long Term Investments LongTermInvestments	44618000	USD
CY2016Q2	us-gaap	Long Term Investments LongTermInvestments	24207000	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	285238000	USD
CY2016Q2	us-gaap	Minority Interest MinorityInterest	230416000	USD
CY2016Q2	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	83400000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	209125000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-204000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	16050000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18466000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5808000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21918000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	359912000	USD
	us-gaap	Net Income Loss NetIncomeLoss	348593000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-8387000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-131456000	USD
CY2015Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3424000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3424000	USD
CY2016Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3612000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-54822000	USD
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	359018000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	346409000	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8387000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-131456000	USD
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	356488000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	345169000	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8387000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-131456000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	21953000	USD
	us-gaap	Operating Expenses OperatingExpenses	21953000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	69147000	USD
	us-gaap	Operating Expenses OperatingExpenses	294143000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-11539000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11539000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-12629000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-188176000	USD
CY2015Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	400000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	400000	USD
CY2016Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1100000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2200000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	USD
CY2016Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9859000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	111000	USD
CY2016Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7972000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-24000	USD
CY2015Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2000	USD
CY2015Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3200000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	14500000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1015000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7260000	USD
CY2015Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	894000	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2184000	USD
CY2016Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4208000	USD
CY2016Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5300000	USD
CY2015Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	209100000	USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	209087000	USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	4000000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	2100000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	38000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	114000	USD
CY2015Q2	us-gaap	Profit Loss ProfitLoss	356488000	USD
	us-gaap	Profit Loss ProfitLoss	345169000	USD
CY2016Q2	us-gaap	Profit Loss ProfitLoss	-11999000	USD
	us-gaap	Profit Loss ProfitLoss	-186278000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	14029000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	21191000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12796000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18468000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	USD
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	6285000	USD
CY2016Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3784000	USD
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	4703000	USD
CY2016Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2205000	USD
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1582000	USD
CY2016Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1579000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	306688000	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	175232000	USD
CY2015Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	10414000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	10414000	USD
CY2015Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13082000	USD
CY2016Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	56518000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	105967000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13082000	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	32756000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	65115000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6154000	USD
CY2015Q3	us-gaap	Share Price SharePrice	19.51
CY2015Q4	us-gaap	Share Price SharePrice	14.73
CY2016Q1	us-gaap	Share Price SharePrice	10.33
CY2015Q4	us-gaap	Short Term Investments ShortTermInvestments	9445000	USD
CY2016Q2	us-gaap	Short Term Investments ShortTermInvestments	27577000	USD
CY2015	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	USD
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	10534000	USD
CY2015	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	39273000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-318000	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	152000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	114000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	649341000	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	537728000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2070000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	934579000	USD
CY2016Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	768144000	USD
CY2015Q2	us-gaap	Technology Services Revenue TechnologyServicesRevenue	2703000	USD
	us-gaap	Technology Services Revenue TechnologyServicesRevenue	2703000	USD
CY2016Q2	us-gaap	Technology Services Revenue TechnologyServicesRevenue	10388000	USD
	us-gaap	Technology Services Revenue TechnologyServicesRevenue	18502000	USD
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36643000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31488000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42594000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42390000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13976000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8513000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42594000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42390000	shares

Files In Submission

Name	View Source	Status
0001628908-16-000060-index-headers.html	Edgar Link	pending
0001628908-16-000060-index.html	Edgar Link	pending
0001628908-16-000060.txt	Edgar Link	pending
0001628908-16-000060-xbrl.zip	Edgar Link	pending
a063016exhibit311.htm	Edgar Link	pending
a063016exhibit312.htm	Edgar Link	pending
a063016exhibit321.htm	Edgar Link	pending
a063016exhibit322.htm	Edgar Link	pending
a063016exhibit991.htm	Edgar Link	pending
evh-20160630.xml	Edgar Link	completed
evh-20160630.xsd	Edgar Link	pending
evh-20160630_cal.xml	Edgar Link	unprocessable
evh-20160630_def.xml	Edgar Link	unprocessable
evh-20160630_lab.xml	Edgar Link	unprocessable
evh-20160630_pre.xml	Edgar Link	unprocessable
evh06301610-q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EVH
Evolent Health, Inc. Stock $evh

2016 Q2 Form 10-Q Financial Statement

#000162890816000060 Filed on August 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVH Evolent Health, Inc. Stock $evh

2016 Q2 Form 10-Q Financial Statement

#000162890816000060 Filed on August 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVH
Evolent Health, Inc. Stock $evh